Comparative Effectiveness of Statin Therapy in Chronic Kidney Disease and Acute Myocardial Infarction: A Retrospective Cohort Study David H. Smith, PhD, RPh, Eric S. Johnson, PhD, MPH, Denise M. Boudreau, RPh, PhD, Andrea E. Cassidy-Bushrow, PhD, Stephen P. Fortmann, MD, Robert T. Greenlee, PhD, MPH, Jerry H. Gurwitz, MD, David J. Magid, MD, MPH, Catherine J. McNeal, MD, PhD, Kristi Reynolds, PhD, MPH, Steven R. Steinhubl, MD, Micah Thorp, DO, Jeffrey O. Tom, MD, MS, Suma Vupputuri, PhD, MPH, Jeffrey J. VanWormer, PhD, Jessica Weinstein, MD, MCR, Xiuhai Yang, MS, Alan S. Go, MD, Stephen Sidney, MD, MPH The American Journal of Medicine Volume 128, Issue 11, Pages 1252.e1-1252.e11 (November 2015) DOI: 10.1016/j.amjmed.2015.06.030 Copyright © 2015 Elsevier Inc. Terms and Conditions
Figure 1 Study design diagram. MI = myocardial infarction. The American Journal of Medicine 2015 128, 1252.e1-1252.e11DOI: (10.1016/j.amjmed.2015.06.030) Copyright © 2015 Elsevier Inc. Terms and Conditions
Figure 2 Cohort assembly. AMI = acute myocardial infarction. The American Journal of Medicine 2015 128, 1252.e1-1252.e11DOI: (10.1016/j.amjmed.2015.06.030) Copyright © 2015 Elsevier Inc. Terms and Conditions
Figure 3 Hazard ratio for death and cardiovascular hospitalization, by level of renal function. eGFR = estimated glomerular filtration rate. The American Journal of Medicine 2015 128, 1252.e1-1252.e11DOI: (10.1016/j.amjmed.2015.06.030) Copyright © 2015 Elsevier Inc. Terms and Conditions